Une entreprise certifiée ISO 9001, 14001, 45001 sales@bldpharm.com
Monnaie :
Langue : Français |
Lieu :
Lieu
  • Americas
    • Europe
      • Asia Pacific
        • Africa & Middle East
          |
          Accueil/ Chemistry/ Asymmetric Synthesis/ Chiral Building Blocks/ (3S,8S,9S,10R,13R,14S,17R)-17-((R)-6-Hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

          (3S,8S,9S,10R,13R,14S,17R)-17-((R)-6-Hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

          CAS NO.: 2140-46-7  
            Taille Prix Sale Price Remise Stock-CN Stock-US Stock-IND Stock-EU Quantité
            How to Order

            The item is temporarily out of stock. Please leave your email address and we will inform you when we have it in stock.

            How to Order

            CONTRÔLE DE QUALITÉ Batch NO.:

            INFORMATION PRODUIT

            Nom du produit : (3S,8S,9S,10R,13R,14S,17R)-17-((R)-6-Hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
            CAS NO. : 2140-46-7 Masse moléculaire : 402.65
            MDL NO. : MFCD00057815 Pureté/Spécification :
            Formule moléculaire : C27H46O2 Stockage : Sealed in dry,Room Temperature
            Point d'ébullition : No data available
            GHS Pictogram :
            Signal Word : Warning Precautionary Statements : P261-P280-P305+P351+P338
            UN# : - Class : -
            Hazard Statements : H302-H312-H315-H319-H332-H335-H373 Packing Group : -

            PRODUITS CONNEXES

            RECORDS HISTORIQUES